MicroRNA-203 regulates caveolin-1 in breast tissue during caloric restriction

Cell Cycle

Volumn 11, Issue 7, 2012, Pages 1291-1295

  Ørom, Ulf Andersson ^a   Lim, Meng K ^a   Savage, Jason E ^b   Jin, Lianjin ^a   Saleh, Anthony D ^b   Lisanti, Michael P ^a   Simone, Nicole L ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Breast cancer; Caloric restriction; Caveolin 1; Longevity; microRNA; p63

Indexed keywords

CAVEOLIN 1; MICRORNA; MICRORNA 203; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BREAST; CALORIC RESTRICTION; CONTROLLED STUDY; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; TISSUE CULTURE;

EID: 84860330710     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.19704     Document Type: Article

References (35)

1. Piper MD, Bartke A. Diet and aging. Cell Metab 2008; 8:99-104; PMID:18680711; http://dx.doi.org/10.1016/j.cmet.2008.06.012.
2. Ye J, Keller JN. Regulation of energy metabolism by inflammation: a feedback response in obesity and calorie restriction. Aging (Albany NY) 2010; 2:361-8; PMID:20606248.
3. Blagosklonny MV. Calorie restriction: decelerating mTOR-driven aging from cells to organisms (including humans). Cell Cycle 2010; 9:683-8; PMID:20139716; http://dx.doi.org/10.4161/cc.9.4.10766.
4. De Lorenzo MS, Baljinnyam E, Vatner DE, Abarzúa P, Vatner SF, Rabson AB. Caloric restriction reduces growth of mammary tumors and metastases. Carcinogenesis 2011; 32:1381-7; PMID:21665891; http://dx.doi.org/10.1093/carcin/ bgr107.
5. Michels KB, Ekbom A. Caloric restriction and incidence of breast cancer. JAMA 2004; 291:1226-30; PMID:15010444; http://dx.doi.org/10.1001/jama.291.10. 1226.
6. Carthew RW, Sontheimer EJ. Origins and Mechanisms of miRNAs and siRNAs. Cell 2009; 136:642-55; PMID:19239886; http://dx.doi.org/10.1016/j.cell.2009.01. 035.
7. Ørom UA, Nielsen FC, Lund AH. MicroRNA-10a binds the 5'UTR of ribosomal protein mRNAs and enhances their translation. Mol Cell 2008; 30:460-71; PMID:18498749; http://dx.doi.org/10.1016/j.molcel.2008.05.001.
8. Vasudevan S, Tong Y, Steitz JA. Switching from repression to activation: microRNAs can upregulate translation. Science 2007; 318:1931-4; PMID:18048652; http://dx.doi.org/10.1126/science.1149460.
9. Ørom UA, Lund AH. Experimental identification of microRNA targets. Gene 2010; 451:1-5; PMID:19944134; http://dx.doi.org/10.1016/j.gene.2009.11. 008.
10. Frankel LB, Christoffersen NR, Jacobsen A, Lindow M, Krogh A, Lund AH. Programmed cell death 4 (PDCD4) is an important functional target of the microRNA miR-21 in breast cancer cells. J Biol Chem 2008; 283:1026-33; PMID:17991735; http://dx.doi.org/10.1074/jbc.M707224200.
11. Lim LP, Lau NC, Garrett-Engele P, Grimson A, Schelter JM, Castle J, et al. Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs. Nature 2005; 433:769-73; PMID:15685193; http://dx.doi.org/10.1038/ nature03315.
12. Nicolas FE, Pais H, Schwach F, Lindow M, Kauppinen S, Moulton V, et al. Experimental identification of microRNA-140 targets by silencing and overexpressing miR-140. RNA 2008; 14:2513-20; PMID:18945805; http://dx.doi.org/10.1261/rna.1221108.
13. Lee SK, Calin GA. Non-coding RNAs and cancer: new paradigms in oncology. Discov Med 2011; 11:245-54; PMID:21447283.
14. Calin GA, Sevignani C, Dumitru CD, Hyslop T, Noch E, Yendamuri S, et al. Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc Natl Acad Sci USA 2004; 101:2999-3004; PMID:14973191; http://dx.doi.org/10.1073/pnas.0307323101.
15. Simone NL, Soule BP, Ly D, Saleh AD, Savage JE, Degraff W, et al. Ionizing radiation-induced oxidative stress alters miRNA expression. PLoS One 2009; 4:6377; PMID:19633716; http://dx.doi.org/10.1371/journal.pone.0006377.
16. Lee CK, Klopp RG, Weindruch R, Prolla TA. Gene expression profile of aging and its retardation by caloric restriction. Science 1999; 285:1390-3; PMID:10464095; http://dx.doi.org/10.1126/science.285.5432.1390.
17. Park SK, Prolla TA. Gene expression profiling studies of aging in cardiac and skeletal muscles. Cardiovasc Res 2005; 66:205-12; PMID:15820189; http://dx.doi.org/10.1016/j.cardiores.2005.01.005.
18. Antosh M, Whitaker R, Kroll A, Hosier S, Chang C, Bauer J, et al. Comparative transcriptional pathway bioinformatic analysis of dietary restriction, Sir2, p53 and resveratrol life span extension in Drosophila. Cell Cycle 2011; 10:904-11; PMID:21325893; http://dx.doi.org/10.4161/cc.10.6.14912.
19. Hursting SD, Lavigne JA, Berrigan D, Perkins SN, Barrett JC. Calorie restriction, aging and cancer prevention: mechanisms of action and applicability to humans. Annu Rev Med 2003; 54:131-52; PMID:12525670; http://dx.doi.org/10. 1146/annurev.med.54.101601.152156.
20. Longo VD, Fontana L. Calorie restriction and cancer prevention: metabolic and molecular mechanisms. Trends Pharmacol Sci 2010; 31:89-98; PMID:20097433; http://dx.doi.org/10.1016/j.tips.2009.11.004.
21. Rous P. The Influence of Diet on Transplanted and Spontaneous Mouse Tumors. J Exp Med 1914; 20:433-51; PMID:19867833; http://dx.doi.org/10.1084/jem. 20.5.433.
22. Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ. Overweight, obesity and mortality from cancer in a prospectively studied cohort of US adults. N Engl J Med 2003; 348:1625-38; PMID:12711737; http://dx.doi.org/10.1056/NEJMoa021423.
23. Beyer DC, Priestley JB Jr. Biochemical diseasefree survival following 125I prostate implantation. Int J Radiat Oncol Biol Phys 1997; 37:559-63; PMID:9112453; http://dx.doi.org/10.1016/S0360-3016(96)00609-8.
24. Segati R, Bari M, Azzarello G, Signorelli C, Marchini M, Fiaccavento G, et al. Carboplatin monochemotherapy in elderly patients with nonoperable transitional cell carcinoma of the bladder: a two-stage, phase II study. Eur Urol 1996; 29:312-6; PMID:8740038.
25. Khanna A, Muthusamy S, Liang R, Sarojini H, Wang E. Gain of survival signaling by downregulation of three key miRNAs in brain of calorierestricted mice. Aging (Albany NY) 2011; 3:223-36; PMID:21415464.
26. Phoenix KN, Vumbaca F, Fox MM, Evans R, Claffey KP. Dietary energy availability affects primary and metastatic breast cancer and metformin efficacy. Breast Cancer Res Treat 2010; 123:333-44; PMID:20204498; http://dx.doi.org/10.1007/s10549-009-0647-z.
27. Martinez I, Cazalla D, Almstead LL, Steitz JA, DiMaio D. miR-29 and miR-30 regulate B-Myb expression during cellular senescence. Proc Natl Acad Sci USA 2011; 108:522-7; PMID:21187425; http://dx.doi.org/10.1073/pnas.1017346108.
28. Ugalde AP, Ramsay AJ, de la Rosa J, Varela I, Mariño G, Cadiñanos J, et al. Aging and chronic DNA damage response activate a regulatory pathway involving miR-29 and p53. EMBO J 2011; 30:2219-32; PMID:21522133; http://dx.doi.org/10.1038/emboj.2011.124.
29. Furuta M, Kozaki KI, Tanaka S, Arii S, Imoto I, Inazawa J. miR-124 and miR-203 are epigenetically silenced tumor-suppressive microRNAs in hepatocellular carcinoma. Carcinogenesis 2010; 31:766-76; PMID:19843643; http://dx.doi.org/10.1093/carcin/bgp250.
30. Viticchiè G, Lena AM, Latina A, Formosa A, Gregersen LH, Lund AH, et al. MiR-203 controls proliferation, migration and invasive potential of prostate cancer cell lines. Cell Cycle 2011; 10:1121-31; PMID:21368580; http://dx.doi.org/10.4161/cc.10.7.15180.
31. Lena AM, Shalom-Feuerstein R, Rivetti di Val Cervo P, Aberdam D, Knight RA, Melino G, et al. miR-203 represses 'stemness' by repressing DeltaNp63. Cell Death Differ 2008; 15:1187-95; PMID:18483491; http://dx.doi.org/10.1038/cdd. 2008.69.
32. Yi R, Poy MN, Stoffel M, Fuchs E. A skin microRNA promotes differentiation by repressing 'stemness'. Nature 2008; 452:225-9; PMID:18311128; http://dx.doi.org/10.1038/nature06642.
33. Lewis BP, Shih IH, Jones-Rhoades MW, Bartel DP, Burge CB. Prediction of mammalian microRNA targets. Cell 2003; 115:787-98; PMID:14697198; http://dx.doi.org/10.1016/S0092-8674(03)01018-3.
34. Williams TM, Sotgia F, Lee H, Hassan G, Di Vizio D, Bonuccelli G, et al. Stromal and epithelial caveolin-1 both confer a protective effect against mammary hyperplasia and tumorigenesis: Caveolin-1 antagonizes cyclin D1 function in mammary epithelial cells. Am J Pathol 2006; 169:1784-801; PMID:17071600; http://dx.doi.org/10.2353/ajpath.2006.060590.
35. Williams TM, Hassan GS, Li J, Cohen AW, Medina F, Frank PG, et al. Caveolin-1 promotes tumor progression in an autochthonous mouse model of prostate cancer: genetic ablation of Cav-1 delays advanced prostate tumor development in tramp mice. J Biol Chem 2005; 280:25134-45; PMID:15802273; http://dx.doi.org/10.1074/jbc.M501186200.